跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xorugen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xorugen
Approved
STANDARD
Xorugen
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b38626d810b29205
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
b38626d810b29205
Drug Approval Philippines Name
Xorugen
Product Name
Xorugen
Registration Number
DRP-13423-02
Brand Name
Xorugen
Generic Name
Doxorubicin Hydrochloride
Dosage Form
Lyophilized Powder for Injection (I.V.)
Dosage Strength
50 mg
Manufacturer
Admac Lifesciences
Importer
Suhitas Pharmaceuticals Inc.
Distributor
Genace Pharma Distributor
Issuance Date
29 March 2024
Expiry Date
15 February 2028
Pharmacologic Category
Antineoplastic (Anthracycline)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b38626d810b29205
Type
Standard
Back to Philippines FDA Approvals